COREY NEERINGS: Open Payments
NPI 1578040465 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 13 payments from 8 companies in 2025. Trend: 2023 $306 · 2024 $392 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, BREZTRI, Kerendia, QULIPTA, Rybelsus, Wegovy, YUPELRI, GARDASIL 9.
Industry payments across UT — which companies pay providers there.
